Mitochondria and Endoplastic Reticulum Targeting Strategy for Enhanced Phototherapy

ACS Appl Bio Mater. 2021 Apr 19;4(4):3015-3026. doi: 10.1021/acsabm.1c00155. Epub 2021 Mar 25.

Abstract

To ensure improved efficacy and minimized toxicity of therapeutic molecules, it is generally accepted that specifically delivering them to the subcellular site of their action will be attractive. Phototherapy has received considerable attention because of its noninvasiveness, high temporal-spatial resolution, and minimal drug resistance. As important functional organelles in cells, mitochondria and endoplasmic reticulum (ER) participate in fundamental cellular processes, which make them much more sensitive to reactive oxygen species (ROS) and hyperthermia. Thus, mitochondria- or ER-targeted phototherapy will be rational strategies for synergetic cancer therapy. In this review, we focus on the latest advances in molecules and nanomaterials currently used for mitochondria- and ER-targeted phototherapy.

Keywords: cancer therapy; endoplasmic reticulum; mitochondria; photodynamic therapy; subcellular targeting.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biocompatible Materials / chemistry
  • Biocompatible Materials / pharmacology*
  • Endoplasmic Reticulum / drug effects*
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum Stress / drug effects
  • Humans
  • Hyperthermia / drug therapy
  • Hyperthermia / metabolism
  • Materials Testing
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Organelles / chemistry*
  • Particle Size
  • Phototherapy*
  • Reactive Oxygen Species / metabolism

Substances

  • Biocompatible Materials
  • Reactive Oxygen Species